(Q36165242)

12 August 2017

1 reference

title

Pharmacoeconomic evaluation of antidepressants : a critical appraisal of methods (English)

1 reference

12 August 2017

Sheikh Usman Iqbal

1

1 reference

12 August 2017

Mark Prashker

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

23

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

595-606

1 reference

Pharmacoeconomics research credibility: a controversial and recurring theme in health outcomes research.

12 August 2017

cites work

1 reference

12 December 2020

Development of a Rating Scale for Primary Depressive Illness

1 reference

12 December 2020

Choosing an antidepressant: effectiveness based pharmacoeconomics

1 reference

12 December 2020

A chronic disease score from automated pharmacy data

1 reference

12 December 2020

A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression

1 reference

12 December 2020

Antidepressants and suicide

1 reference

12 December 2020

Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders

1 reference

12 December 2020

The health economic impact of antidepressant usage from a payer's perspective: a multinational study.

1 reference

12 December 2020

Are SSRIs a cost-effective alternative to tricyclics?

1 reference

12 December 2020

Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology

1 reference

12 December 2020

The evolution of quality management in state Medicaid agencies: a national survey of states with comprehensive managed care programs.

1 reference

12 December 2020

Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide

1 reference

12 December 2020

Economic comparisons of the pharmacotherapy of depression: an overview

1 reference

12 December 2020

Fluoxetine-induced sexual dysfunction and an open trial of yohimbine

1 reference

12 December 2020

Cost implications of initial antidepressant selection in primary care

1 reference

12 December 2020

Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study

1 reference

12 December 2020

Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses

1 reference

12 December 2020

Depression: treatment compliance in general practice.

1 reference

12 December 2020

Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.

1 reference

12 December 2020

Adequacy and duration of antidepressant treatment in primary care

1 reference

12 December 2020

Disappearance of memory deficits in outpatient depressives responding to imipramine

1 reference

12 December 2020

The importance of accidents in evaluating the cost of SSRIs: a review.

1 reference

12 December 2020

A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases

1 reference

12 December 2020

The role of the primary care physician in patients' adherence to antidepressant therapy.

1 reference

12 December 2020

The economic impact of depression in a workplace.

1 reference

12 December 2020

A critical review of selected pharmacoeconomic analyses of antidepressant therapy

1 reference

12 December 2020

Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada

1 reference

12 December 2020

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

12 December 2020

A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders.

1 reference

12 December 2020

Economic appraisal of antidepressant pharmacotherapy: critical review of the literature and future directions

1 reference

12 December 2020

A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care

1 reference

12 December 2020

Economic evaluation of paroxetine and imipramine in depressed outpatients

1 reference

12 December 2020

The need for an iterative process for assessing economic outcomes associated with SSRIs

1 reference

12 December 2020

Cost-effectiveness of treatments for major depression in primary care practice

1 reference

12 December 2020

Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.

1 reference

12 December 2020

The course of depression in adult outpatients. Results from the Medical Outcomes Study

1 reference

12 December 2020

Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization.

1 reference

12 December 2020

What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment

1 reference

12 December 2020

Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles.

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis

1 reference

12 December 2020

10.2165/00019053-200523060-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1049655990

0 references

1 reference